BioNote, Inc. (377740.KS)
KSE · KRW · Healthcare · Medical Devices
₩4,500 (-2.07%) as of
Key statistics
- Market cap
- 454.11B
- Dividend yield
- 4.96%
- 52-week range
- 4,050.00 – 6,260.00
- Beta
- 0.63
- Revenue (TTM)
- 126.41B
- Profit margin
- -99.43%
- Volume
- 38.79k
About BioNote, Inc.
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hwaseong-si, South Korea
- Employees
- 299
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.